0001104659-24-010102.txt : 20240202
0001104659-24-010102.hdr.sgml : 20240202
20240202164847
ACCESSION NUMBER: 0001104659-24-010102
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240201
FILED AS OF DATE: 20240202
DATE AS OF CHANGE: 20240202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Phillips Jack
CENTRAL INDEX KEY: 0001784805
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31822
FILM NUMBER: 24592320
MAIL ADDRESS:
STREET 1: 11731 YALE DR
CITY: CARMEL
STATE: IN
ZIP: 46032
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Accelerate Diagnostics, Inc
CENTRAL INDEX KEY: 0000727207
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 841072256
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3950 S. COUNTRY CLUB ROAD #470
STREET 2: BUILDING 3-307
CITY: TUCSON
STATE: AZ
ZIP: 85714
BUSINESS PHONE: 303-863-8088
MAIL ADDRESS:
STREET 1: 3950 S. COUNTRY CLUB ROAD #470
STREET 2: BUILDING 3-307
CITY: TUCSON
STATE: AZ
ZIP: 85714
FORMER COMPANY:
FORMER CONFORMED NAME: ACCELR8 TECHNOLOGY CORP
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: HYDRO SEEK INC
DATE OF NAME CHANGE: 19880802
4
1
tm245035-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-02-01
0
0000727207
Accelerate Diagnostics, Inc
AXDX
0001784805
Phillips Jack
C/O ACCELERATE DIAGNOSTICS, INC.
3950 S. COUNTRY CLUB ROAD, SUITE 470
TUCSON
AZ
85714
1
1
0
0
Chief Executive Officer
0
Common Stock
2024-02-01
4
M
0
1000
0
A
77201
D
Common Stock
2024-02-01
4
S
0
494
1.30
D
76707
D
Employee Restricted Stock Units
2024-02-01
4
M
0
1000
0
D
Common Stock
1000
1000
D
The reporting person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of the issuer's common stock for each RSU upon vesting. On February 1, 2020, the reporting person was granted a total of 5,000 RSUs, which vest in equal annual amounts on each anniversary of the grant date over five years, beginning on February 1, 2021 and ending on February 1, 2025.
The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.
/s/ David Patience, attorney-in-fact
2024-02-02